Effect of trichomoniasis therapy on genital HIV viral burden among African women

Sexually Transmitted Diseases

Volumn 39, Issue 8, 2012, Pages 638-642

  Anderson, Brenna L ^a   Firnhaber, Cynthia ^b,c   Liu, Tao ^d   Swarts, Avril ^b   Siminya, Maureen ^c   Ingersoll, Jessica ^e   Caliendo, Angela M ^e   Cu Uvin, Susan ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c RIGHT TO CARE   (South Africa)

^d BROWN UNIVERSITY   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE;

ADULT; AFRICA; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; GENITAL ULCER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOAFFINITY CHROMATOGRAPHY; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; SCREENING; SINGLE DRUG DOSE; TRICHOMONIASIS; VIRUS LOAD;

ADOLESCENT; ADULT; ANTIPROTOZOAL AGENTS; COHORT STUDIES; FEMALE; HIV SEROPOSITIVITY; HUMANS; METRONIDAZOLE; MIDDLE AGED; PROSPECTIVE STUDIES; SOUTH AFRICA; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; VAGINA; VIRAL LOAD; VIRUS SHEDDING; YOUNG ADULT;

EID: 84863798338     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31825725ad     Document Type: Article

References (33)

1. Gerbase AC, Rowley JT, Heymann DH, et al. Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect 1998; 74(suppl 1):S12-S16.
2. Johnston VJ, Mabey DC. Global epidemiology and control of Trichomonas vaginalis. Curr Opin Infec Dis 2008; 21:56-64.
3. Bachmann LH, Hobbs MM, Seña AC, et al. Trichomonas vaginalis genital infections: Progress and challenges. Clin Infect Dis 2011; 53(suppl 3):S160-S172.
4. Watson-Jones D, Mugeye K, Mayaud P, et al. High prevalence of trichomoniasis in rural men in Mwanza, Tanzania: Results from a population based study. Sex Transm Infect 2000; 76:355-362.
5. Wilkinson D, Ndovela N, Harrison A, et al. Family planning services in developing countries: An opportunity to treat asymptomatic and unrecognised genital tract infections? Genitourin Med 1997; 73:558-560. (Pubitemid 28064703)
6. Mhlongo S, Magooa P, Muller EE, et al. Etiology and STI/HIV coinfections among patients with urethral and vaginal discharge syndromes in South Africa. Sex Transm Dis 2010; 37:566-570.
7. Anorlu RI, Fagbenro Beyioku AF, Fagorala T, et al. Prevalence of Trichomonas vaginalis in patients with vaginal discharge in Lagos, Nigeria. Niger Postgrad Med J 2001; 8:183-186.
8. Buve A, Weiss HA, Laga M, et al. The epidemiology of trichomoniasis in women in four African cities. AIDS 2001; 15 (suppl 4):S89-96. (Pubitemid 32913008)
9. Schwebke JR. Trichomoniasis in adolescents: A marker for the lack of a public health response to the epidemic of sexually transmitted diseases in the United States. J Infect Dis 2005; 192:2036-2038. (Pubitemid 41779198)
10. Swygard H, Sena AC, Hobbs MM, et al. Trichomoniasis: Clinical manifestations, diagnosis and management. Sex Transm Infect 2004; 80:91-95. (Pubitemid 38496831)
11. Shafir SC, Sorvillo FJ, Smith L. Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microbiol Rev 2009; 22:37-45.
12. Chesson HW, Blandford JM, Pinkerton SD. Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States. Sex Transm Dis 2004; 31:547-551. (Pubitemid 39122137)
13. Narimatsu R, Wolday D, Patterson BK. IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res Hum Retroviruses 2005; 21:228-233. (Pubitemid 40478231)
14. Al-Harthi L, Kovacs A, Coombs RW, et al. A menstrual cycle pattern for cytokine levels exists in HIV-positive women: Implication for HIV vaginal and plasma shedding. AIDS 2001; 15: 1535-1543. (Pubitemid 32744601)
15. Crowley-Nowick PA, Ellenberg JH, Vermund SH, et al. Cytokine profile in genital tract secretions from female adolescents: Impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis 2000; 181:939-945. (Pubitemid 30194477)
16. Olaitan A, Johnson MA, Reid WM, et al. Changes to the cytokine microenvironment in the genital tract mucosa of HIV+ women. Clin Exp Immunol 1998; 112:100-104. (Pubitemid 28157105)
17. Mitchell C, Hitti J, Paul K, et al. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota. AIDS Res Hum Retroviruses 2011; 27:35-39.
18. Price MA, Zimba Da, Hoffman IF, et al. Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: A randomized clinical trial. Sex Transm Dis 2003; 30:516-522. (Pubitemid 36667033)
19. Wang CC, McClelland RS, Reilly M, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis 2001; 183:1017-1022. (Pubitemid 32230948)
20. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342:921-929. (Pubitemid 30177052)
21. Cu-Uvin S, Snyder B, Harwell JI, et al. Association between paired plasma and cervicovaginal lavage fluid HIV-1 RNA levels during 36 months. J Acquir Immune Defic Syndr 2006; 42:584-587. (Pubitemid 44162427)
22. Anderson BL, Cu-Uvin S. Determinants of HIV shedding in the lower genital tract of women. Curr Infect Dis Rep 2008; 10:505-511.
23. Baeten JM, Kahle E, Lingappa JR, et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 2011; 3:77ra29.
24. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
25. Diggle PJ, Heagerty P, Liang KY, et al. Analysis of Longitudinal Data. 2nd ed. Oxford, England: Oxford University Press, 2002.
26. Nagot N, Ouedraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007; 356:790-799. (Pubitemid 46294611)
27. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427-439.
28. Hayes R, Watson-Jones D, Celum C, et al. Treatment of sexually transmitted infections for HIV prevention: End of the road or new beginning? AIDS 2010; 24(suppl 4):S15-26.
29. Sha BE, Zariffard MR, Wang QJ, et al. Female genital-tract HIV load correlates inversely with lactobacillus species but positively with bacterial vaginosis and mycoplasma hominis. J Infect Dis 2005; 191:25-32. (Pubitemid 40041396)
30. Cu-Uvin S, Hogan JW, Caliendo AM, et al. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 2001; 33:894-896. (Pubitemid 32831848)
31. Spinillo A, Debiaggi M, Zara F, et al. Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions. BJOG 2001; 108:634-641. (Pubitemid 33646506)
32. Cohn JA, Hashemi FB, Camarca M, et al. HIV-inducing factor in cervicovaginal secretions is associated with bacterial vaginosis in HIV-1-infected women. J Acquir Immune Defic Syndr 2005; 39:340-346. (Pubitemid 40923216)
33. Coleman JS, Hitti J, Bukusi EA, et al. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 2007; 21:755-759. (Pubitemid 46568633)